As of January 2025, Mycenax Biotech has a market cap of $276.50M. This makes Mycenax Biotech the world's 14711th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $244.06M | 8.54% |
2023 | $224.85M | -4.80% |
2022 | $236.19M | -1.06% |
2021 | $238.71M | 17.70% |
2020 | $202.81M | 38.20% |
2019 | $146.75M | -9.69% |
2018 | $162.50M | -2.09% |
2017 | $165.96M | -22.50% |
2016 | $214.14M | -29.46% |
2015 | $303.58M | -14.08% |
2014 | $353.34M | -20.54% |
2013 | $444.66M | 143.45% |
2012 | $182.65M | - |